Inactivated Polio Vaccine (IPV) Administered

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.ama-assn.org/go/cpt",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 4
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2021-09-14T01:01:12-04:00",
  "meta" : {
    "versionId" : "22",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for an inactivated polio vaccination (IPV).),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent an inactivated polio vaccination (IPV).),(Exclusion Criteria: No exclusions.)",
  "name" : "InactivatedPolioVaccineIPVAdministered",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.ama-assn.org/go/cpt",
      "code" : "90697",
      "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use",
      "version" : "2025"
    }, {
      "system" : "http://www.ama-assn.org/go/cpt",
      "code" : "90698",
      "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use",
      "version" : "2025"
    }, {
      "system" : "http://www.ama-assn.org/go/cpt",
      "code" : "90713",
      "display" : "Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use",
      "version" : "2025"
    }, {
      "system" : "http://www.ama-assn.org/go/cpt",
      "code" : "90723",
      "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use",
      "version" : "2025"
    } ],
    "total" : 4,
    "identifier" : "urn:uuid:6be1e933-5723-4b0c-b7e4-e3cd892edd82",
    "timestamp" : "2024-12-10T10:34:05-05:00"
  },
  "title" : "Inactivated Polio Vaccine (IPV) Administered",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "NCQA PHEMUR Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-02-14",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2021-09-14",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "dcbd5e82-651b-467c-a554-4f9ee36704ef",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1117"
  } ],
  "version" : "20210914"
}